AU Patent
AU2006200857A1 — y-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
Assigned to Les Laboratoires Servier SAS · Expires 2010-01-28 · 16y expired
What this patent protects
Patent listed against Corlanor.
Drugs covered by this patent
- Corlanor (IVABRADINE) · Amgen
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.